Abon Biopharma has a total of 348 patents globally, out of which 257 have been granted. Of these 348 patents, more than 39% patents are active. China is where Abon Biopharma has filed the maximum number of patents, followed by United States of America and Hong Kong (S.A.R.). Parallelly, China seems to be the main focused R&D centre and also is the origin country of Abon Biopharma.
Abon Biopharma was founded in the year 2003. The Company manufactures in vitro diagnostic products. The Company produces and sells ketamine drug screen test devices, fecal occult blood test devices, syphilis ultra-rapid test devices, chlamydia antigen test devices, and other products.
Do read about some of the most popular patents of Abon Biopharma which have been covered by us in this article and also you can find Abon Biopharma patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Abon Biopharma patent portfolio.
How many patents does Abon Biopharma have?
Abon Biopharma has a total of 348 patents globally. These patents belong to 238 unique patent families. Out of 348 patents, 139 patents are active.
How Many Patents did Abon Biopharma File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Abon Biopharma Applications Filed | Abon Biopharma Patents Granted |
| 2021 | – | 1 |
| 2020 | – | 5 |
| 2019 | – | 17 |
| 2018 | 8 | 23 |
| 2017 | 15 | 31 |
| 2016 | 21 | 25 |
| 2015 | 28 | 23 |
| 2014 | 45 | 26 |
| 2013 | 48 | 16 |
| 2012 | 35 | 27 |
| 2011 | 39 | 16 |
How many Abon Biopharma patents are Alive/Dead?
How Many Patents did Abon Biopharma File in Different Countries?
Countries in which Abon Biopharma Filed Patents
| Country | Patents |
| China | 289 |
| United States of America | 13 |
| Hong Kong (S.A.R.) | 10 |
| Europe | 8 |
| Germany | 3 |
| Spain | 2 |
| Austria | 2 |
| Taiwan | 2 |
| United Kingdom | 1 |
| Canada | 1 |
Where are Research Centres of Abon Biopharma Patents Located?
10 Best Abon Biopharma Patents
USD762860S1 is the most popular patent in the Abon Biopharma portfolio. It has received 30 citations so far from companies like Life Technologies Corporation, Neogen Corporation and Altopa, Inc.
Below is the list of 10 most cited patents of Abon Biopharma:
| Publication Number | Citation Count |
| USD762860S1 | 30 |
| CN101876661A | 30 |
| CN101545864A | 21 |
| CN105829861A | 19 |
| CN101059404A | 19 |
| WO2008014709A1 | 19 |
| CN201212889Y | 16 |
| CN203869898U | 14 |
| CN201464268U | 14 |
| CN203083995U | 13 |
What Percentage of Abon Biopharma US Patent Applications were Granted?
Abon Biopharma (Excluding its subsidiaries) has filed 4 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 2 have been granted leading to a grant rate of 50.0%.
Below are the key stats of Abon Biopharma patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Abon Biopharma?
| Law Firm | Total Applications | Success Rate |
| Dla Piper Llp Us | 4 | 50.00% |
What are Abon Biopharma key innovation segments?
What Technologies are Covered by Abon Biopharma?
The chart below distributes patents filed by Abon Biopharma in different countries on the basis of the technology protected in patents. It also represents the markets where Abon Biopharma thinks it’s important to protect particular technology inventions.
R&D Focus: How has Abon Biopharma search focus changed over the years?
EXCLUSIVE INSIGHTS COMING SOON!